SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Far below the surface, where light no longer reaches and noise collapses into silence, the Sperm Whale endures.  It does not rely on speed or spectacle. It survives through mass, intelligence, and absolute awareness of its surroundings.  This project is shaped by the same principle — strength formed under pressure, movement guided by understanding, and conviction built where others cannot remain.  While the surface reacts, the deep decides.

The Sperm Whale

SPERMWHALE is driving significant community debate as traders split between those chasing high-volatility meme coin gains and others warning of a potential rug pull or scam. While some proponents highlight its unique structure and rapid momentum as signs of a breakout, skeptics are actively pointing to its low holder count and lack of fundamental utility.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Compute and Networking Business Unit (CNBU), Mobile Business Unit (MBU), Embedded Business Unit (EBU), and Storage Business Unit (SBU). The CNBU segment includes memory products and solutions sold into client, cloud server, enterprise, graphics, and networking markets. The MBU segment is involved in memory and storage products sold into smartphone and other mobile-device markets. The EBU segment focuses on memory and storage products sold into automotive, industrial, and consumer Markets. The SBU segment consists of SSDs and component-level solutions sold into enterprise and cloud, client, and consumer storage markets. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron Technology is experiencing significant volatility as investors debate the impact of geopolitical tensions in the Middle East against the backdrop of an aggressive AI-driven supercycle. While community members highlight robust earnings and long-term demand for HBM chips as a potential floor for the stock, ongoing confusion surrounding potential U.S.-Iran diplomatic talks has led to intense short-term selling and widespread speculation about institutional market manipulation.

Fundrise Innovation Fund LLC. - Common Shares of Limited Liability Company Interests

Fundrise Innovation Fund 

VCX is experiencing extreme volatility and intense community interest following its NYSE debut, driven by its access to high-profile private tech holdings like Anthropic and SpaceX. Investors are actively debating the sustainability of the stock's massive premium over its net asset value, fueled by a restricted float due to a six-month lockup period that prevents early shareholders from selling.

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Biocryst Pharmaceuticals Inc.

Biocryst Pharmaceuticals is currently trending due to unconfirmed, high-volume market activity and persistent speculation regarding a potential M&A event. Community discussions are heavily focused on the stock's significant after-hours volume and historical parallels to recent biotech buyouts, with many investors debating the plausibility of a deal while weighing the company's established commercial growth against long-term pipeline potential.

Merlin, Inc. is an aerospace and defense technology company focused on developing autonomous flight solutions. The company is building an operating system of record for autonomous aviation, with its Merlin Pilot system enabling a wide range of aircraft and mission profiles. Its technology has been validated through hundreds of autonomous flights conducted at test facilities worldwide. The company is headquartered in Boston, MA.

Merlin Inc.

Marlin Business Services Corp.

Marlin Business Services is currently a focal point for investors due to significant confusion surrounding its identity, with many traders debating whether the ticker refers to the historical financial services firm or the newly public Merlin Inc. in the AI aviation sector. The community is actively discussing the stock's potential for momentum-driven moves and high-volatility spikes, while many retail participants remain focused on the recent transition from a special purpose acquisition company.

ProShares Trust - ProShares Ultra VIX Short-Term Futures ETF 1.5x Shares

ProShares Ultra VIX Short-Term Futures ETF

UVXY is attracting significant community attention as traders debate whether current volatility surrounding Middle Eastern geopolitical tensions justifies a bullish position or represents a trap in a fundamentally decaying asset. While some investors are betting on a major spike driven by potential energy infrastructure disruptions and broader market uncertainty, others are actively warning against holding the ETF long-term, advocating for shorting or buying puts on any upward price bounces.

Coinbase Wrapped BTC ("cbBTC") is a token that is backed 1:1 by native Bitcoin (BTC) held by Coinbase, meaning that for all cbBTC in circulation, there is an equivalent amount of BTC held in a secure custody solution (including cold storage) provided by Coinbase. Wrapped assets, like cbBTC, are transferable tokens that are redeemable for the underlying asset. Coinbase customers can unwrap cbBTC and redeem a corresponding amount of the underlying BTC simply by depositing the cbBTC into their Coinbase accounts. cbBTC is built to be seamlessly compatible with DeFi applications, giving customers the option to tap into DeFi and unlock financial utility. cbBTC removes a key point of friction by allowing customers to use Bitcoin they already hold in new ways onchain. cbBTC is built to be seamlessly compatible with DeFi applications, so users can now tap into novel DeFi use cases like providing their Bitcoin as liquidity to DeFi protocols, using it as collateral to borrow other crypto assets, or spending it as a payment method. Wrapped assets like cbBTC are a mature concept in the crypto world, helping to bring more liquid assets onchain and facilitate an expansive financial ecosystem.

Coinbase Wrapped BTC

Community interest in CBBTC is currently driven by its integration with various Bitcoin mining partnerships and yield-generating protocols on the Base network, allowing holders to passively earn airdrops. Investors are actively discussing the potential of these mechanisms, often framing them as a unique opportunity to accumulate yield-bearing assets alongside their standard holdings.

SPDR Gold Trust - SPDR Gold Shares

SPDR Gold Shares ETF

SPDR Gold Shares (GLD) is experiencing intense volatility and downward pressure as investors rotate out of gold, which has lost its traditional safe-haven status amid the ongoing Iran-U.S. conflict. The community is actively debating whether this represents a long-term capitulation or a temporary liquidity flush, with many retail traders expressing frustration over the asset's recent performance compared to tech and equity markets.

The Estée Lauder Companies, Inc. engages in the manufacture of skin care, makeup, fragrance and hair care products. It sells products under Estée Lauder, Clinique, Origins, MAC, Bobbi Brown, La Mer, Jo Malone London, Aveda and Too Faced. The company was founded by Estee Lauder and Joseph Lauder in 1946 and is headquartered in New York, NY.

Estee Lauder Cos., Inc. - Ordinary Shares - Class A

Estee Lauder Cos. Inc

Estee Lauder (EL) shares are currently seeing significant volatility and investor chatter as the market reacts to ongoing merger talks with Spanish beauty powerhouse Puig, while the company concurrently navigates a challenging turnaround plan. The community is sharply divided, with many debating whether the stock represents a deep-value opportunity in luxury beauty or if it remains trapped by restructuring hurdles, negative income, and broader headwinds from international tariffs.

Carvana Co. is a holding company and an eCommerce platform, which engages in the buying and selling of used cars. The company was founded by Ernest Garcia, III, Benjamin Huston and Ryan Keeton in 2012 and is headquartered in Tempe, AZ.

Carvana Co. - Ordinary Shares - Class A

Carvana Co.

Carvana is currently at the center of polarized debate following its board's approval of a 5-for-1 stock split, which bulls view as a catalyst for increased retail accessibility and liquidity, while bears characterize it as a tactical move to mask underlying fundamental weaknesses. Community sentiment remains intensely divided between investors betting on a continued parabolic trajectory and those anticipating a structural collapse, with active discussions focusing on high-level insider selling, subprime loan delinquency concerns, and the impact of the stock's S&P 500 inclusion.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

What is HC Wainwright's Forecast for FHTX FY2026 Earnings?

Foghorn Therapeutics Inc. (NASDAQ:FHTX - Free Report) - HC Wainwright boosted their FY2026 earnings per share (EPS) estimates for Foghorn Therapeutics in a report released on Thursday, March 12th. HC...

Foghorn Therapeutics (NASDAQ:FHTX) Downgraded to Hold Rating by Wall Street Zen

Wall Street Zen cut Foghorn Therapeutics from a "buy" rating to a "hold" rating in a research report on Saturday...

Brokers Offer Predictions for FHTX FY2030 Earnings

Foghorn Therapeutics Inc. (NASDAQ:FHTX - Free Report) - Investment analysts at HC Wainwright issued their FY2030 earnings estimates for shares of Foghorn Therapeutics in a research report issued to...

Foghorn Therapeutics (NASDAQ:FHTX) Earns "Outperform" Rating from Wedbush

Wedbush reiterated an "outperform" rating and issued a $10.00 price objective on shares of Foghorn Therapeutics in a research report on Thursday...

Foghorn Therapeutics Inc. (FHTX) Reports Q4 Loss, Beats Revenue Estimates

Foghorn Therapeutics (FHTX) delivered earnings and revenue surprises of -19.72% and +14.87%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

Foghorn Therapeutics (NASDAQ:FHTX) Issues Quarterly Earnings Results, Misses Expectations By $0.04 EPS

Foghorn Therapeutics (NASDAQ:FHTX - Get Free Report) posted its quarterly earnings data on Wednesday. The company reported ($0.34) EPS for the quarter, missing analysts' consensus estimates of...

HC Wainwright Reiterates Buy Rating for Foghorn Therapeutics (NASDAQ:FHTX)

HC Wainwright restated a "buy" rating and set a $13.00 price objective on shares of Foghorn Therapeutics in a research note on Tuesday...

Verastem (VSTM) Reports Q4 Loss, Beats Revenue Estimates

Verastem (VSTM) delivered earnings and revenue surprises of -2.04% and +0.20%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

Foghorn Therapeutics (FHTX) Projected to Post Earnings on Thursday

Foghorn Therapeutics (NASDAQ:FHTX) will be releasing its Q4 2025 earnings before the market opens on Thursday, March 5. (View Earnings Report at...

Foghorn Therapeutics (NASDAQ:FHTX) Rating Increased to Strong-Buy at Jefferies Financial Group

Jefferies Financial Group raised Foghorn Therapeutics to a "strong-buy" rating in a report on Tuesday...

Foghorn Therapeutics, Inc. operates as a development stage biopharmaceutical company. It is discovering and developing a novel class of precision medicine therapeutics targeting the chromatin regulatory system in oncology. Through its scalable Gene Traffic Control product platform, the firm is systematically interrogating and drugging the chromatin regulatory system. The company was founded by Cigall Kadoch, Gerald W. Crabtree and Douglas G. Cole in October 2015 and is headquartered in Cambridge, MA.

FHTX
Foghorn Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest FHTX News

FHTXFoghorn Therapeutics Inc